Neuroderm Cash Flow - Annual (NASDAQ:NDRM)

Add to My Stocks
$38.85 $0 (0%) NDRM stock closing price Oct 18, 2017 (Closing)

The Neuroderm cash flow statement is one of the three reports that the company generates every quarter. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Neuroderm profits one has to check the income statement and for Neuroderm debt one has to check the balance sheet. Neuroderm had cash and cash equivalents of $84.73M at beginning of the year and $107.17M at year end for 2016. Neuroderm cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. The cash from operating activities for Neuroderm is $ 2016, which saw a decrease from previous year.

View details of Neuroderm cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec20162015201420132012
Net Income Cash Flow
-32.49M-15.6M-29.86M-86.89M-4.57M
Depreciation Depletion Amortization Cash-Flow-----
Net Increase (Decrease) in Assets Liabilities--2.08M---
Cash From (used in) Discontinued Operations-----
Other Adjustments Net3.96M2.21M21.74M83.74M1.73M
Net Cash from (used by) Operating Activities
-27.78M-15.43M-7.98M-2.53M-2.27M
Increase (Decrease) in Prop Plant And Equipment-0.85M-0.07M-0.11M-0.01M-
Acquisition Disposition of Subsidiaires-----
Increase (Decrease) in Investments-30M-14.96M---
Other Cash Inflow (Outflow) from Investment Activities--0.05M-0.05M--0.67M
Net Cash from (used by) Investment Activities
-30.85M-15.09M-0.16M--0.67M
Issuance (Purchase) of Equity Shares81.04M72.02M49.23M3.2M4.3M
Issuance (Repayment) of Debt Securities-----
Increase (Decrease) in Bank & Other Borrowings-----
Payment of Dividends & Other Cash Distributions-----
Other Cash from (used by) Financing Activities-----
Net Cash from (used by) Financing Activities
81.04M72.02M49.23M3.2M4.3M
Effect of Exchange Rate Changes on Cash---0.28M-0.75M-
Net Change in Cash & Cash Equivalents
22.44M41.49M40.8M-1.35M
Cash & Equivalents at Beginning of Year84.73M43.23M2.43M1.84M-
Cash & Equivalents at Year End107.17M84.73M43.23M2.43M1.84M
All figures in USD. M: Millions of USD, B: Billions of USD.

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Neuroderm stock price history and Neuroderm stock comparison chart inevitably reflect its cash flow situation.

  • Neuroderm had a Net Change in Cash and Cash Equivalents of $22.44M for the latest year 2016. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the Neuroderm stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-27.78M for NDRM.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-30.85M for NDRM in last 2016 report.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $81.04M for Neuroderm.

Key Financial Ratios For Neuroderm Cash Flow